OPCH Stock Recent News
OPCH LATEST HEADLINES
OPCH, COMM, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 22, 2025.
OPCH, COMM and JD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 17, 2025.
OPCH, COMM and JD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 15, 2025.
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today April 9th:
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 3, 2025.
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 1, 2025.
Option Care (OPCH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BANNOCKBURN, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2025 on Tuesday, April 29, 2025 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.